Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: Gordon James who wrote (957)	9/3/1999 4:03:00 PM
From: caly	Read Replies (1) \| Respond to of 2515

Thanks for pointing that out, Gordon. I got to those links by going through an "Ongoing Clinical Trials" link from NCI. I assumed they'd be up to date. I had noticed this on the IMCL website though, and just assumed I had the right trial: breast cancer a dose-ranging phase Ib/IIa study for patients with metastatic disease in combination with taxol, the study's objectives are to determine the pharmacologic, safety and efficacy profiles of the combination therapy. This study is open to enrollment. imclone.com